Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Layla vs OurView Health

Layla
Graded #103

Higher grade

vs+3.6000000000000085
OurView Health
Graded #172

Lower grade

The verdict

Layla takes it — 70.9/100 to 67.3/100.

Layla grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Layla is a US telehealth weight-loss program built around semaglutide, offering compounded semaglutide as injections and as oral dropper drops, plus compounded tirzepatide and a brand-inclusive GLP-1…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOurView Health +9
66
75
Dose & formulationLayla +32
96
64
Clinical oversightOurView Health +3
76
79
Labs & monitoringOurView Health +1
52
53
FulfillmentOurView Health +5
65
70
Contract termsLayla +10
55
45
Layla · left barOurView Health · right bar

The numbers

MetricLaylaOurView Health
WeighScore70.9/10067.3/100
GradeCC
Scorecard rank#103#172
Semaglutide$237/mo (all doses, compounded)$75/mo (starting dose, compounded)
Tirzepatide$199/mo (all doses, compounded)$135/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Layla

Graded #103 · C

Strengths

  • Oral semaglutide dropper option plus injectable semaglutide and tirzepatide, with a brand-name upgrade path
  • Named Medical Director (Dr. Ruth Cohen) and 24-7 doctor messaging
  • Quiz-based intake with fast three to five day shipping

Where it loses points

  • Brand-inclusive GLP-1 program is expensive, starting around 1,299 dollars
  • States served are not published on the site
  • Support phone line uses a UK format, and the compounding pharmacy is not named
OurView Health

Graded #172 · C

Strengths

  • Low starting prices via the Savings Club — compounded semaglutide from $75, tirzepatide from $135
  • Clear product pricing with no contracts; medication shipped to your door (30-day supply)
  • Full legal suite published (Terms, Privacy, HIPAA Notice, Returns & Refunds)
  • Discloses meds are compounded by a licensed third-party pharmacy; multi-vertical (TRT, HRT, BHRT, peptides)

Where it loses points

  • 'Starting at' prices likely require Savings Club membership and/or a longer plan
  • Compounding pharmacy partner not named ('licensed third-party pharmacy')
  • 'LegitScript Approved' is stated on the site but was not independently verified here
  • Operating medical entity not clearly named (site operated by a marketing agency)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard